Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Partial-onset Seizures”

194 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 194 results

Testing effectiveness (Phase 2)Study completedNCT00236873
What this trial is testing

The Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.

Who this might be right for
EpilepsyEpilepsies, PartialSeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 47
Large-scale testing (Phase 3)Study completedNCT00744731
What this trial is testing

An Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures

Who this might be right for
Epilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more
SK Life Science, Inc. 403
Post-approval studies (Phase 4)WithdrawnNCT02220972
What this trial is testing

To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

Who this might be right for
Epilepsy, Partial
Eisai Inc.
Post-approval studies (Phase 4)Study completedNCT00659958
What this trial is testing

ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs

Who this might be right for
Epilepsy
Eisai Inc. 32
Large-scale testing (Phase 3)Study completedNCT01142193
What this trial is testing

Study to Evaluate the Safety and Effectiveness of USL255 in Patients With Refractory Partial-onset Seizures

Who this might be right for
Epilepsy
Upsher-Smith Laboratories 249
Testing effectiveness (Phase 2)Study completedNCT00938431
What this trial is testing

A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures

Who this might be right for
Epilepsy
UCB Pharma 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04015141
What this trial is testing

Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy

Who this might be right for
Pediatric Epileptic SyndromePartial-onset Seizures
Eisai Inc. 100
Testing effectiveness (Phase 2)Study completedNCT03754582
What this trial is testing

Intravenous Perampanel in Japanese Participants With Epilepsy

Who this might be right for
EpilepsySeizures
Eisai Co., Ltd. 21
Early research (Phase 1)Study completedNCT00426673
What this trial is testing

An Open-Label Interaction Study to Look at the Effects of Brivaracetam on Phenytoin When Taken Together in 15 Adult Patients With Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma 15
Testing effectiveness (Phase 2)Study completedNCT00465517
What this trial is testing

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Who this might be right for
Partial EpilepsyCatamenial Epilepsy
Marinus Pharmaceuticals 147
Large-scale testing (Phase 3)Study completedNCT00566254
What this trial is testing

Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)

Who this might be right for
Epilepsy; Paediatric Partial Onset Seizures
Eisai Inc. 207
Post-approval studies (Phase 4)Study completedNCT00713622
What this trial is testing

Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate

Who this might be right for
Epilepsy
Eisai Limited 2
Large-scale testing (Phase 3)Study completedNCT00975715
What this trial is testing

Efficacy, Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures

Who this might be right for
Partial Onset Seizures
Novartis Pharmaceuticals 99
Testing effectiveness (Phase 2)Study completedNCT02150213
What this trial is testing

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Who this might be right for
Adrenocortical AdenomaEndometrial Stromal Sarcomas
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Study completedNCT00280696
What this trial is testing

Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
UCB Japan Co. Ltd. 352
Large-scale testing (Phase 3)Study completedNCT01964560
What this trial is testing

A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures

Who this might be right for
Epilepsy
UCB BIOSCIENCES, Inc. 540
Post-approval studies (Phase 4)Study completedNCT01318408
What this trial is testing

Levetiracetam: The Anti-Convulsant of Choice for Elderly Patients With Dementia

Who this might be right for
Epilepsy
Drexel University College of Medicine 24
Large-scale testing (Phase 3)WithdrawnNCT00175864
What this trial is testing

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

Who this might be right for
Epilepsy
UCB Pharma
Large-scale testing (Phase 3)Active Not RecruitingNCT05067634
What this trial is testing

Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 140
Large-scale testing (Phase 3)Study completedNCT02535091
What this trial is testing

Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Who this might be right for
Partial Epilepsy
SK Life Science, Inc. 1,345
Next Page